Keeping Current Medscape Podcasts
-
- Health & Fitness
Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.
-
Multiple Sclerosis Biosimilars in Europe: How to Communicate With Your Patient for Successful Implementation
Did you know that specific words and gestures you use can cause the nocebo effect?
Credit available for this activity expires: 6/10/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000861?ecd=bdc_podcast_libsyn_mscpedu -
A Deep Dive Into Long-Term Efficacy and Safety of LDL-Cholesterol Lowering: Modern Strategies for ASCVD
Are you up to date on low-density lipoprotein cholesterol (LDL-C)–lowering therapy in high-risk patients?
Credit available for this activity expires: 06/06/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000828?ecd=bdc_podcast_libsyn_mscpedu -
Antibody-Drug Conjugates in the Spotlight: Novel Strategies for Breast Cancer Management
Are you up to date on the key clinical data on ADCs in breast cancer -- especially those that set the stage for upcoming data releases?
Credit available for this activity expires: 5/31/2024
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000851?ecd=bdc_podcast_libsyn_mscpedu -
Decoding Epilepsy Treatment Strategies: A Case-Based Exploration
Combining data, guidelines, and experience to select appropriate treatments for individuals with focal epilepsy.
Credit available for this activity expires: 5/31/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000865?ecd=bdc_podcast_libsyn_mscpedu -
Delivering Precision Oncology to Patients: From Principles to Practice
How can molecular profiling guide cancer therapy? Join our experts to learn how to best utilize molecular testing in clinical practice.
Credit available for this activity expires: 5/30/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001132?ecd=bdc_podcast_libsyn_mscpedu -
Chronic Inflammatory Demyelinating Polyneuropathy: How Insights From Disease Biology Inform Novel Therapies
Did you know that more than 20% of patients with chronic inflammatory demyelinating polyneuropathy (CIDP) do not respond to current first-line treatments?
Credit available for this activity expires: 5/30/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000839?ecd=bdc_podcast_libsyn_mscpedu